Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and postoperative sleep quality in children after tonsil adenoidectomy
ChiCTR2400083375Phase 4Not yet recruiting
- Sponsor
- Affiliated Women and Children's Hospital of Ningbo University
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in sleep disorder, postoperative delirium (POD) and Postoperative behavioral change (2 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoint: Postoperative sleep quality. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorderpostoperative delirium (POD)Postoperative behavioral change
Beyond the preview
Go deeper on ChiCTR2400083375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083375.